POINT Biopharma Global Inc.
PNTDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811764
POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding POINT Biopharma Global Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 84 | 106 | +22 |
| Shares | 48.5M | 60.9M | +12.3M (+25.4%) |
| Value | $330.5M | $470.4M | +$140.0M (+42.4%) |
New holders (32)
Institutions that held POINT Biopharma Global Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (10)
Institutions that held POINT Biopharma Global Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 9,003,018 | $61.3M |
| RTW Investments, LP | 490,000 | $3.34M |
| HRT Financial LP | 308,236 | $2.10M |
| Oracle Investment Management Inc | 129,810 | $884.0K |
| Trexquant Investment LP | 33,244 | $226.0K |
| Clarkston Capital Partners, LLC | 22,545 | $154.0K |
| Sigma Planning Corp | 19,480 | $133.0K |
| Victory Capital Management Inc | 11,395 | $78.0K |
| Penserra Capital Management LLC | 3,606 | $24.0K |
| Point72 Hong Kong Ltd | 210 | $1.00K |